InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by CARR EDWARD, Chief Financial Officer. Officer active across 1 companies, notably Abeona Therapeutics INC.. Aggregated, 4 disclosures have been logged. Total volume traded: €53k. The latest transaction was filed on 8 October 2021 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations4 total
€26,46729,122 shares@ €0.90880.0091% mcap100.0% of flow
Common stock
SEC:0001493152-21-025082·
€26,46729,122 shares@ €0.90880.0091% mcap50.0% of flow
Common stock
SEC:0001493152-21-025082:0·
0238,000 shares0
Common stock
SEC:0001493152-21-019498·
0238,000 shares0
Common stock
SEC:0001493152-21-019498:0·
4 of 4 declarations
About CARR EDWARD
Edward Carr is the Chief Financial Officer at ABEONA THERAPEUTICS INC. In this role, he oversees the company's financial operations, including financial planning, risk management, and compliance. With deep expertise in finance and corporate strategy, he plays a crucial role in making financial decisions that support the organization's growth and profitability. His leadership is essential for ensuring the financial health of the company.
